SCHEMBL4978113

SCHEMBL4978113

Cc1ccc(-n2cnc3cnc(N)nc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XDH P47989 1/20 0.48
▸ DHFR P00374 2/20 0.44
▸ HCAR1 Q9BXC0 1/20 0.43
▸ RPS6KA3 P51812 1/20 0.41
▸ MAPK6 Q16659 1/20 0.40
▸ GRM1 Q13255 2/20 0.39
▸ FGFR1 P11362 1/20 0.39
▸ RAB9A P51151 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ HTT P42858 1/20 0.38
▸ NPC1 O15118 2/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ MAPT P10636 2/20 0.37
▸ ESR1 P03372 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ HPGD P15428 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29139810 0.84 FGFR1 (0.47) XDHDHFRHCAR1FGFR1RAB9A
SCHEMBL17052498 0.81 HCAR1 (0.43) XDHHCAR1RPS6KA3MAPK6FGFR1
SCHEMBL17802582 0.80 CFTR (0.54) RPS6KA3FGFR1SMN1; SMN2KDM4EALDH1A1
SCHEMBL2409198 0.78 HDAC6 (0.52) RPS6KA3FGFR1KDM4EALDH1A1HDAC6
Phenol SCHEMBL28142595 0.78 FGFR1 (0.49) RPS6KA3FGFR1HTTESR1ESR2
SCHEMBL426847 0.76 HCAR1 (0.48) XDHDHFRHCAR1RAB9ASMN1; SMN2
SCHEMBL30684918 0.76 MAPKAPK2 (0.57) DHFR
SCHEMBL27745688 0.76 PI4KA (0.52) HCAR1KDM4EHTTHDAC6MAPT
SCHEMBL27870413 0.75 XDH (0.58) XDHDHFRGRM1
SCHEMBL6945092 0.75 HDAC6 (0.64) SMN1; SMN2KDM4EALDH1A1HTTHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101454325-A 8-heteroarylpurine MNK2 inhibitors for the treatment of metabolic disorders PHARMACOPEIA INC (US) 2009-06-10 — — CN claimed
EP-1991547-A2 8-HETEROARYLPURINE MNK2 INHIBITORS FOR TREATING METABOLIC DISORDERS PHARMACOPEIA, INC. (US) 2008-11-19 — — EP claimed
WO-2007104053-A2 8-HETEROARYLPURINE MNK2 INHIBITORS FOR TREATING METABOLIC DISORDERS PHARMACOPEIA, INC. (US) 2007-09-13 — — WO claimed
CN-101454325-A 8-heteroarylpurine MNK2 inhibitors for the treatment of metabolic disorders PHARMACOPEIA INC (US) 2009-06-10 — — CN disclosed
EP-1991547-A2 8-HETEROARYLPURINE MNK2 INHIBITORS FOR TREATING METABOLIC DISORDERS PHARMACOPEIA, INC. (US) 2008-11-19 — — EP disclosed
WO-2007104053-A2 8-HETEROARYLPURINE MNK2 INHIBITORS FOR TREATING METABOLIC DISORDERS PHARMACOPEIA, INC. (US) 2007-09-13 — — WO disclosed
Send feedback